Market revenue in 2023 | USD 1,120.7 million |
Market revenue in 2030 | USD 1,729.2 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 89.8% in 2023. Horizon Databook has segmented the Europe implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
According to the European Society of Cardiology, around 49 million people in the region suffer from CVD. There were 6 million new cases of CVD in 2019, which cost around USD 232 billion (EUR 210 billion) a year.
The major causes of death in European countries are stroke and Ischemic Heart Disease (IHD). The Central and Eastern European countries recorded a higher prevalence of CVDs than the Northern, Western, & Southern.
Moreover, according to the European Commission, sudden cardiac arrests (SCA) accounts for approximately 20% of the deaths in the region. Moreover, the European Resuscitation Council launched ESCAPE-NET project, which aims to group the leading European scientific teams who have large population cohorts focusing on SCA.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe implantable cardioverter defibrillators market , including forecasts for subscribers. This continent databook contains high-level insights into Europe implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account